ELI LILLY & Co 4

EVP Melissa Seymour reported two small non-open-market transfers of Eli Lilly common stock (17 shares in 2025 and 12 shares in 2026), modestly reducing her direct holdings.

On this Form 4, Melissa Seymour, EVP, Global Quality at Eli Lilly & Co, reports two small, previously unreported transactions coded as “G” (typically indicating a non-open-market, gift or similar transfer) of common stock. On 2025-09-22, 17 shares of common stock were transferred, reducing her direct holdings from approximately 1,067.373 shares to 1,050.373 shares, and on 2026-09-09, 12 additional shares were transferred, further reducing her direct holdings from 1,050.373 shares to 1,038.373 shares. Based on the current price of about $1,115.70 per share, these transfers represent de minimis dollar amounts relative to the company’s market value, and appear as routine personal or administrative equity movements rather than meaningful open-market trading activity.

Filing Facts

CIK

59478

Ticker

LLY

Form

4

Source Type

fda

Accession

0002032089-26-000004

Alert Tier

4